UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  June 2, 2016

 

ROCKWELL MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

Michigan

 

000-23661

 

38-3317208

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

30142 Wixom Road, Wixom, Michigan

 

48393

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code            (248) 960-9009

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07                                           Submission of Matters to a Vote of Security Holders.

 

On June 2, 2016, Rockwell Medical, Inc. (the “Company”) held its Annual Meeting of Shareholders.  At the Annual Meeting the shareholders (1) reelected one incumbent director for a term expiring in 2019, (2) did not approve the Company’s 2016 Long Term Incentive Plan, and (3) ratified the selection of Plante & Moran, PLLC as the Company’s independent registered public accounting firm for 2016.  The following tables set forth the final voting results on each matter.

 

Director Nominee

 

For

 

Withheld

 

Broker Non-Votes

 

Ronald D. Boyd

 

14,011,364

 

10,981,850

 

22,314,175

 

 

Proposal

 

For

 

Against

 

Abstain

 

Broker Non-
Votes

 

Approve the 2016 LTIP

 

11,977,282

 

12,806,542

 

209,390

 

22,314,175

 

Ratify the selection of Plante & Moran, PLLC

 

43,453,090

 

3,746,013

 

108,286

 

—

 

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ROCKWELL MEDICAL, INC.

 

 

 

 

 

Date: June 6, 2016

By:

/s/ Thomas E. Klema

 

 

Thomas E. Klema

 

 

Its: Chief Financial Officer

 

3